Smart Money Is Racing Into the Biotech Boom

The biotech boom is back. After its big breakthrough a few years ago, the biotech industry fell silent. Now, it is in the spotlight once again as smart money races in to back some once-in-a-generation breakthroughs.  Mentioned in today's commentary includes:  CRISPR Therapeutics AG (NASDAQ: CRSP), Sangamo Therapeutics, Inc. (NASDAQ: SGMO),  Microsoft Corporation (NASDAQ: MSFT), International Business Machines Corporation (NYSE: IBM), Apple Inc. (NASDAQ: AAPL). From exciting new technology to the FDA's 'fast-tracking' of brand new therapies for a wide range of treatments, the biotech industry has once again found itself at exactly the right place at exactly the right time. Before investing, however, it's essential to know every detail about a company - and their particular niche. Not only is the industry notorious for small companies exploding and then promptly losing it all, but it's also on the cusp of brand new and potentially major breakthroughs, meaning that without the proper government green lights, even the most brilliant projects could be shut down in the blink of an eye.  And with the industry growing faster than ever, it's never been more important to stay ahead of these trends and regulations. From industry giants like Microsoft to breakout start-ups like Champignon Brands (SHRM;SHRMF) - the next great quantum physics or biotech boom is all about positioning yourself. That's why we've put together an outline of everything you need to know about one of the most exciting trends in the biotech sector as it expands in 2020.